At Daiichi Sankyo, we are united by a single purpose, to improve lives around the world through innovative medicines. With a legacy of innovation since 1899, a presence in more than 30 countries, and more than 19,000 employees, we are advancing breakthrough therapies in oncology, cardiovascular disease, rare diseases, and immune disorders. Guided by our 2030 vision to "be an innovative global healthcare company contributing to the sustainable development of society", we are shaping a healthier, more hopeful future for patients, their families, and society.
The Position
As a core member of the Global Oncology Medical Affairs (GOMA) Leadership Team, this role is accountable for shaping the GOMA CDx vision and objectives as well as the holistic Companion Diagnostics Medical Affairs strategies for molecules and therapeutic areas where DS operates in oncology. This role will also oversee the execution of the global medical affairs activities related biomarkers and CDx, ensuring alignment with pipeline priorities and precision medicine goals. This role and their team will partner closely across several functions within Global Oncology Medical Affairs, Regional Medical Affairs, Precision Medicine, Clinical Development, RWE/HEOR, Discovery and Business Development as well as Oncology Business Unit Leadership Team.
Roles and Responsibilities
Strategic Leadership & Cross-Functional Alignment (30%)
Driving the overarching medical strategy for Companion Diagnostics (CDx), fostering alignment across multiple functions and stakeholders to accelerate precision medicine efforts and maximize patient impact.
- Shape and define enterprise-level CDx priorities in collaboration with Medical and Cross-Functional Partners, ensuring alignment with broader portfolio and business objectives.
- Serve as strategic partner and advisor to Franchise Heads, GMAT, MAST leads, and regional CDx leaders, facilitating cohesive and future-forward business decisions.
- Influence and inform cross-functional strategies across Precision Medicine, Clinical Development, Commercial and Market Access strategies to enable integrated, patient-centric approaches.
- Leverage AI, emerging technologies, and data-driven insights to inform CDx strategy development, identify opportunities, and optimize cross-functional planning and execution.
Medical Strategy Execution & Scientific Excellence (40%)
Lead execution of global medical strategy for Companion Diagnostics (CDx) across the oncology portfolio, driving readiness, scientific leadership, and strategic alignment with internal and external partners.
- Drive global medical readiness for CDx launches and lifecycle management across the oncology portfolio, ensuring timely, integrated execution.
- Ensure strategic coherence and executional alignment of CDx medical initiatives with alliance partners and internal stakeholders, fostering a unified approach to shared objectives.
- Identify and work to address critical evidence and educational gaps through targeted strategies (e.g., scientific education, clinical studies) to advance biomarker and CDx understanding and application.
- Review and approve internal and external biomarker and CDx-related study proposals to ensure scientific integrity and strategic fit.
- Build and maintain high-impact, trusted partnerships with external thought leaders, diagnostic companies, and central labs to shape external understanding and adoption of CDx strategies.
- Collaborate with global and regional PAG leads to shape integrated medical strategies informed by precision medicine and biomarker insights.
Enterprise Leadership & Medical Impact (30%)
Lead cross-functional medical initiatives, contribute to enterprise-wide strategic direction, and drive operational excellence within Global Oncology Medical Affairs.
- Actively contribute to the strategic direction and operational excellence of Global Oncology Medical Affairs (GOMA), serving as a member of the GOMA Leadership Team and influencing long-range planning.
- Lead and participate in cross-functional medical initiatives, helping shape strategic decisions with insights from internal and external stakeholders.
- Provide strategic leadership and direction to team of biomarker and CDx experts, ensuring alignment with global medical and organizational priorities.
- Develop and manage the annual operating plan and budget for the GOMA biomarkers and CDx team.
- Define, monitor, and interpret KPIs associated with CDx strategies and tactics to assess impact, guide decision making, and optimize future organizational strategies.
Personal skills and professional experience:
- MD, PharmD, DO, PhD or other doctorate degree required
- At least 5 years experience managing direct reports.
- Demonstrated track record of success leading multidisciplinary CDx development teams within a pharmaceutical company.
- Excellent knowledge of current clinical practice in Oncology / Hematology or other relevant disease area.
- Understanding of medical activities (including scientific communications, medical information, MSLs, and HEOR), relating to the commercialization of oncology products.
- Superior strategic leadership skills with a strong ability to define, prioritize and balance team responsibilities in accordance with business and department needs.
- Effectively manages activities and optimize resources and budget to meet business needs; have excellent project management skills.
- Effectively engage external stakeholders across a broad range of audiences and activities such as evidence generation projects, publications, medical information and education, Advisory Boards, Scientific Exchange), patient educational activities.
- Broad knowledge and understanding of established and new assay technologies.
- Knowledge of drug development process and a strong understanding of how diagnostic development can shape drug development and commercialization.
- Expertly manage ambiguity and highly complex situations.
- Have excellent communications skills and ability to convey complex scientific concepts simply and effectively.
- Fluent English (oral and written).
